<DOC>
	<DOCNO>NCT01603394</DOCNO>
	<brief_summary>The primary objective explore whether sensory symptom cluster analysis useful predict treatment response Postherpetic Neuralgia .</brief_summary>
	<brief_title>Pilot Study Of Pregabalin And Prediction Of Treatment Response In Patients With Postherpetic Neuralgia</brief_title>
	<detailed_description>The study stop 26 April 2013 due feasibility issue ( low enrollment ) safety . The overall risk-benefit Lyrica change due termination trial . Only 9 150 patient enrolled trial , unable get adequate result study .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia , Postherpetic</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Subjects must pain present 3 month heal herpes zoster skin rash . At screen ( V1 ) baseline ( V2 ) , subject must score &gt; =4 Numeric Rating Scale Pain ( 1 week recall period ) . At baseline ( V2 ) , least 4 pain diary must complete satisfactorily within last 7 day average pain score must &gt; =4 . Subjects severe pain may confound assessment self evaluation pain due PHN . Neurolytic neurosurgical therapy Postherpetic Neuralgia Skin condition affect dermatome could alter sensation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>